Rebecca C.Martin

Partner

New York + 1.212.326.3410

Rebecca Martin has decades of experience in investigations and litigations involving the federal False Claims Act (FCA), Anti-Kickback Statute (AKS), Stark Law, Food, Drug and Cosmetics Act (FDCA), and other health care and privacy matters. She has extensive experience handling cases involving state false claims act and consumer protection laws.

The clients Rebecca serves include medical device and diagnostic companies, pharmaceutical manufacturers, multistate physician practices, private equity sponsors and portfolio companies, diagnostic laboratories, digital and telemedicine health providers, academic medical centers and hospitals, post-acute facilities, DME (durable medical equipment) suppliers, home health agencies, and government contractors. Rebecca has obtained highly favorable results in litigations and government investigations in FCA and other matters. A recognized thought leader in the field, Rebecca writes and speaks regularly regarding FCA and fraud and abuse issues.

Rebecca is a 15-year veteran of the United States Attorney's Office for the Southern District of New York (SDNY), where she served as co-chief of the Civil Frauds Unit and health care fraud coordinator. As co-chief, she was responsible for a full range of matters involving FCA and civil financial fraud. She handled and supervised groundbreaking matters that resulted in billions of dollars in recoveries for the government during her tenure. Rebecca's portfolio included the health care, pharmaceutical, research, financial, and government contracting industries. Rebecca's work involved extensive coordination with numerous federal agencies, including the FBI, HHS-Office of Inspector General and Centers for Medicare and Medicaid Services, SEC, Tricare (uniformed services health care program), and state Attorney General Offices.

Esperienze

  • Digital health companies, specialty hospitals, and health systems maintain compliance with multistate requirements through 50-state surveyJones Day is representing digital health companies, specialty hospitals, and health systems in maintaining compliance with multistate requirements through a regularly updated, extensive 50-state survey on state laws and regulations applicable to telehealth activities of physicians and other health care professionals including licensing, establishing patient relationships, provider-to-provider consulting, supervision and delegation among providers, and prescribing and treatment standards.
    • August 2020
      Compliance Round-Up: City Bar Series on COVID-19’s Impact on Ethics and Compliance: COVID-19 Lending Programs: Latest Developments (New York City Bar)
    • April 2020
      Is the Tsunami Coming? Potential Litigation and Regulatory Risks for Lenders under the Recently Enacted Covid-19 Loan Programs (New York City Bar Webinar)
    • January 2020
      Analyzing the Government’s Evaluation of a Qui Tam Action (6th Annual Advanced Forum on False Claims & Qui Tam Enforcement)
    • September 2019
      False Claims Act and Healthcare Fraud (2019 American Bar Association Healthcare Delivery and Innovation Conference)
    • May 2019
      Critical Legal Issues (2019 Physician Practice Management and ASC Symposium)
    • January 2019
      How DOJ Decides When to Intervene and an Update on Criminal/Civil Concurrent Investigations (5th Annual Advanced Forum on False Claims & Qui Tam Enforcement)
    • July 2017
      Whistleblowing and Recent Developments, National Society for Corporate Governance, The Golden State of Governance Annual Conference, San Francisco
    • January 2017
      False Claims Act Enforcement Trends, Practicing Law Institute Annual Conference
    • November 2016
      Self-Disclosures: When, Where and How, Health Care Investigations and Litigation, (November 2016)
    • November 2016
      Navigating Legal Challenges, PLI Life Science Conference
    • September 2016
      Reverse False Claims and the 60-Day Rule, HCCA Boston Regional Annual Compliance Conference
    • October 2014
      Enforcement Trends, Practising Law Institute’s Health Care and Life Sciences Law 2014
    • September 2014
      Program Integrity and Enforcement: The Government Perspective, NYSBA, Health Law Section
    • January 2014
      Law Enforcement Panel, CBI Pharmaceutical Compliance Congress